All news from Rheumatology

The Way To Sore Knee Relief Cartilage Repair

NIBIB-developed researchers have developed a 3-D-printed scaffold coated aggregate, a native cartilage component, to improve the regeneration of cartilage tissue in joints. The scaffold was combined with a common microfracture procedure and tested in rabbits. University of Maryland researchers found the combination of the implant and microfracture procedure to be ten times more effective than microfracture alone. Microfracture alone is the standard therapy currently.

Surgeons Offer New Option For arthritis In The Big Toe

The big toe on Pattie Bostick-Winn's right foot was excruciatingly painful, likely the result of her 10 years as a professional dancer in Broadway-style shows. Often, she had to wear heels on the stage, and by age 48, the cartilage had worn away between the bones connecting her big toe to the ball of her foot.

Estrogen May Protect Menisci Between Thighbone And Shinbone

More than 30 million Americans suffer from osteoarthritis of the knee, according to the Centers for Disease Control and Prevention. The degenerative joint disease, often caused by wear and tear, is a leading cause of disability in the U.S. Partly triggered by a breakdown in the fibrocartilage between the bones of the knee joint such as the meniscus, osteoarthritis results in pain, stiffness and less range of motion.

Hormone Therapy Against knee Osteoarthritis

There is an ongoing debate regarding the relationship between knee osteoarthritis and hormone therapy (HT), with small-scale studies providing mixed results. A new large-scale study from Korea shows that women receiving HT had a significantly lower prevalence of symptomatic knee osteoarthritis compared with women who did not take hormones.

Honoraria: Consulting Linked to Positive RA

The first study to document the prevalence and structure of financial conflicts of interest (FCOI) among authors of rheumatoid arthritis (RA) randomized clinical trials (RCTs) found no overall impact of authors' FCOI or of funding source on study outcomes. The study did see, however, that tests were more likely to be positive if an author had received honoraria or consulting fees from the sponsoring drug company.

Study: Most Drug Fail to Control Long-term OA Pain

The first meta-analysis of long-term pharmacologic treatments for knee osteoarthritis (OA) found little evidence that most prescribed medications improve pain control or preserve joint structure after 12 months of treatment. There was a small but statistically and clinically significant benefit from prescription-grade glucosamine sulfate .